(Q39538019)

12 September 2017

title

Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro (English)

1 reference

12 September 2017

Peng Wang

1

1 reference

12 September 2017

Xiao-Min Zou

2

1 reference

12 September 2017

Jian Huang

3

1 reference

12 September 2017

Tian-Lan Zhang

4

1 reference

12 September 2017

Kui Wang

5

1 reference

12 September 2017

publication date

1 November 2011

1 reference

Cell Biology International

12 September 2017

published in

1 reference

12 September 2017

volume

35

1 reference

12 September 2017

issue

11

1 reference

12 September 2017

page(s)

1159-1167

1 reference

Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Lanthanide containing compounds for therapeutic care in bone resorption disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

The critical role of the bone microenvironment in cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Clinical features of metastatic bone disease and risk of skeletal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

The therapeutic application of lanthanides

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Role of integrins in cell invasion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Pathogenesis of osteoblastic bone metastases from prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Motexafin gadolinium: a novel redox active drug for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Cell signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Potential anticancer properties of bisphosphonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

The "emigration, migration, and immigration"of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Osteoclasts are active in bone forming metastases of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

RANK ligand as a therapeutic target for bone metastases and multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Acacetin, a flavonoid, inhibits the invasion and migration of human prostate cancer DU145 cells via inactivation of the p38 MAPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Lanthanum suppresses osteoblastic differentiation via pertussis toxin-sensitive G protein signaling in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Dynamic process of prostate cancer metastasis to bone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Extracellular Gd-CA: differences in prevalence of NSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Targeting factors involved in bone remodeling as treatment strategies in prostate cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Osteoblast response to hydroxyapatite doped with divalent and trivalent cations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

Inhibition of p38 MAPK reduces tumor conditioned medium-induced angiogenesis in co-cultured human umbilical vein endothelial cells and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20100870

21 January 2018

Identifiers

DOI

10.1042/CBI20100870

1 reference

12 September 2017

1 reference